Researcher plays key role in discovery of new drug target for stopping the spread of malaria.
Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
Researchers at Griffith University’s Eskitis Institute for Drug Discovery have developed a new technique for discovering natural compounds which could lead to novel therapeutic drugs.
Institute for Glycomics researchers awarded $1.1 million from NHMRC to develop new antibiotics for drug resistant gonorrhoea.
Repurposed medications may guide future strategies for COVID-19 treatment.
A Griffith University-led research team has discovered how a therapeutic target common among debilitating neurodegenerative disorders is activated, which could help accelerate drug development.
A new method of identifying molecular targets to fight disease could help accelerate future drug development new Griffith University research has found.
A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis (tumour spread) and drug resistance.
Scientists from Griffith’sInstitute for Glycomics have teamed up withGermany’s Fraunhofer Institute for Toxicology and Experimental Medicine ITEM and the Hannover...
Researchers find commonly used antimalarial drug has better activity against malaria parasites than previously thought.
